Patents by Inventor Klaus Luetzenkirchen

Klaus Luetzenkirchen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Radionuclides for medical use
    Patent number: 7794691
    Abstract: Methods of using Th-226 or mother radionuclides thereof, namely U-230 or Th-226, in medicine. These radionuclides are particularly appropriate for the treatment of human and/or non-human mammals, in particular for therapeutic, diagnostic (detection/imaging), prophylactic and pain palliation purposes. These radionuclides may be used in various forms for treatment and/or diagnostic purposes, in particular in cationic form or in the form of radioconjugates or bone-targeting complexes. Methods of making such radionuclides.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: September 14, 2010
    Assignee: The European Community, represented by the European Commission
    Inventors: Alfred Morgenstern, Christos Apostolidis, Roger Molinet, Klaus Luetzenkirchen
  • RADIONUCLIDES FOR MEDICAL USE
    Publication number: 20100189642
    Abstract: Methods of using Th-226 or mother radionuclides thereof, namely U-230 or Th-226, in medicine. These radionuclides are particularly appropriate for the treatment of human and/or non-human mammals, in particular for therapeutic, diagnostic (detection/imaging), prophylactic and pain palliation purposes. These radionuclides may be used in various forms for treatment and/or diagnostic purposes, in particular in cationic form or in the form of radioconjugates or bone-targeting complexes. Methods of making such radionuclides.
    Type: Application
    Filed: June 25, 2004
    Publication date: July 29, 2010
    Applicant: THE EUROPEAN COMMUNITY
    Inventors: Alfred Morgenstern, Christos Apostolidis, Roger Molinet, Klaus Luetzenkirchen